A coumarin sulfamates series was made as part of this development programme, one of which, 4-methylcoumarin-7-O-sulfamate (Figure 2, Compound 4, COUMATE), inhibited STS activity in MCF-7 breast cancer cells by >90% at 10 μM [89]. Here, STS is linked to breast carcinoma.